Healthcare Advisory Platform
Working with investors, founders, boards, and executive teams to solve complex challenges and accelerate value creation across healthcare and life sciences.
Practice Areas
Healthcare Strategy
Growth, positioning, partnerships & investor readiness.
Investment Intelligence
Commercial diligence, scientific review & risk evaluation.
Growth Execution
Turnarounds, transactions & executive advisory.
We work across the healthcare and life sciences ecosystem with investors, founders, boards, and executive teams that need clear thinking, rapid analysis, and senior-level execution.
Engagement style
Confidential, responsive, and tailored to the complexity of each situation.
Clients rely on us for clarity, speed, discretion, and practical execution when the decisions are too important to get wrong.
Contact Us→Growth strategy, market expansion, partnerships, leadership planning, investor readiness.
Commercial diligence, scientific review, management assessment, market sizing, risk evaluation.
Performance improvement, restructuring support, KPI redesign, revenue acceleration.
Acquisition support, target screening, integration planning, strategic transaction execution.
We combine the depth of specialists with the rigor of investors and the pragmatism of operators. Clients value our commitment to clarity, speed, confidentiality, and practical outcomes.
Sharpening complex decisions into a clear path forward.
Moving with urgency when timing is decisive.
Discretion as a baseline expectation in every engagement.
Our most experienced people on every engagement, every time.
Strategy that translates into measurable, real-world results.
Founder, President & Chief Investment Officer
Healthcare strategist and industry leader with deep experience across pharmaceuticals, clinical development, regulation, and investment.
Chief Operating Officer
Operating executive with cross-sector experience in fund operations, portfolio oversight, and biotechnology leadership.
Portfolio Manager
Healthcare investor combining biomedical research depth with thematic investing and portfolio construction expertise.
by Michael Jeong, MD
A strategic perspective on how the Make America Healthy Again initiative could impact investment strategies in the life sciences.